1 Report Business Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Adult T-Cell Leukemia & Lymphoma Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Brentuximab Vedotin 1.2.3 HBI-8000 1.2.4 Others 1.3 Market by Application 1.3.1 Global Adult T-Cell Leukemia & Lymphoma Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Ambulatory Surgical Centers 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Adult T-Cell Leukemia & Lymphoma Treatment Market Perspective (2017-2028) 2.2 Adult T-Cell Leukemia & Lymphoma Treatment Growth Trends by Region 2.2.1 Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Adult T-Cell Leukemia & Lymphoma Treatment Historic Market Size by Region (2017-2022) 2.2.3 Adult T-Cell Leukemia & Lymphoma Treatment Forecasted Market Size by Region (2023-2028) 2.3 Adult T-Cell Leukemia & Lymphoma Treatment Market Dynamics 2.3.1 Adult T-Cell Leukemia & Lymphoma Treatment Industry Trends 2.3.2 Adult T-Cell Leukemia & Lymphoma Treatment Market Drivers 2.3.3 Adult T-Cell Leukemia & Lymphoma Treatment Market Challenges 2.3.4 Adult T-Cell Leukemia & Lymphoma Treatment Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Adult T-Cell Leukemia & Lymphoma Treatment Players by Revenue 3.1.1 Global Top Adult T-Cell Leukemia & Lymphoma Treatment Players by Revenue (2017-2022) 3.1.2 Global Adult T-Cell Leukemia & Lymphoma Treatment Revenue Market Share by Players (2017-2022) 3.2 Global Adult T-Cell Leukemia & Lymphoma Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Adult T-Cell Leukemia & Lymphoma Treatment Revenue 3.4 Global Adult T-Cell Leukemia & Lymphoma Treatment Market Concentration Ratio 3.4.1 Global Adult T-Cell Leukemia & Lymphoma Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Adult T-Cell Leukemia & Lymphoma Treatment Revenue in 2021 3.5 Adult T-Cell Leukemia & Lymphoma Treatment Key Players Head office and Area Served 3.6 Key Players Adult T-Cell Leukemia & Lymphoma Treatment Product Solution and Service 3.7 Date of Enter into Adult T-Cell Leukemia & Lymphoma Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Adult T-Cell Leukemia & Lymphoma Treatment Breakdown Data by Type 4.1 Global Adult T-Cell Leukemia & Lymphoma Treatment Historic Market Size by Type (2017-2022) 4.2 Global Adult T-Cell Leukemia & Lymphoma Treatment Forecasted Market Size by Type (2023-2028) 5 Adult T-Cell Leukemia & Lymphoma Treatment Breakdown Data by Application 5.1 Global Adult T-Cell Leukemia & Lymphoma Treatment Historic Market Size by Application (2017-2022) 5.2 Global Adult T-Cell Leukemia & Lymphoma Treatment Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Adult T-Cell Leukemia & Lymphoma Treatment Market Size (2017-2028) 6.2 North America Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Type 6.2.1 North America Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Type (2017-2022) 6.2.2 North America Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Type (2023-2028) 6.2.3 North America Adult T-Cell Leukemia & Lymphoma Treatment Market Share by Type (2017-2028) 6.3 North America Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Application 6.3.1 North America Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Application (2017-2022) 6.3.2 North America Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Application (2023-2028) 6.3.3 North America Adult T-Cell Leukemia & Lymphoma Treatment Market Share by Application (2017-2028) 6.4 North America Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Country 6.4.1 North America Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Country (2017-2022) 6.4.2 North America Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Country (2023-2028) 6.4.3 U.S. 6.4.4 Canada 7 Europe 7.1 Europe Adult T-Cell Leukemia & Lymphoma Treatment Market Size (2017-2028) 7.2 Europe Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Type 7.2.1 Europe Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Type (2017-2022) 7.2.2 Europe Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Type (2023-2028) 7.2.3 Europe Adult T-Cell Leukemia & Lymphoma Treatment Market Share by Type (2017-2028) 7.3 Europe Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Application 7.3.1 Europe Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Application (2017-2022) 7.3.2 Europe Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Application (2023-2028) 7.3.3 Europe Adult T-Cell Leukemia & Lymphoma Treatment Market Share by Application (2017-2028) 7.4 Europe Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Country 7.4.1 Europe Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Country (2017-2022) 7.4.2 Europe Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Adult T-Cell Leukemia & Lymphoma Treatment Market Size (2017-2028) 8.2 Asia-Pacific Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Type 8.2.1 Asia-Pacific Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Type (2017-2022) 8.2.2 Asia-Pacific Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Type (2023-2028) 8.2.3 Asia-Pacific Adult T-Cell Leukemia & Lymphoma Treatment Market Share by Type (2017-2028) 8.3 Asia-Pacific Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Application 8.3.1 Asia-Pacific Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Application (2017-2022) 8.3.2 Asia-Pacific Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Application (2023-2028) 8.3.3 Asia-Pacific Adult T-Cell Leukemia & Lymphoma Treatment Market Share by Application (2017-2028) 8.4 Asia-Pacific Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Region 8.4.1 Asia-Pacific Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Region (2017-2022) 8.4.2 Asia-Pacific Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Adult T-Cell Leukemia & Lymphoma Treatment Market Size (2017-2028) 9.2 Latin America Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Type 9.2.1 Latin America Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Type (2017-2022) 9.2.2 Latin America Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Type (2023-2028) 9.2.3 Latin America Adult T-Cell Leukemia & Lymphoma Treatment Market Share by Type (2017-2028) 9.3 Latin America Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Application 9.3.1 Latin America Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Application (2017-2022) 9.3.2 Latin America Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Application (2023-2028) 9.3.3 Latin America Adult T-Cell Leukemia & Lymphoma Treatment Market Share by Application (2017-2028) 9.4 Latin America Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Country 9.4.1 Latin America Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Country (2017-2022) 9.4.2 Latin America Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Adult T-Cell Leukemia & Lymphoma Treatment Market Size (2017-2028) 10.2 Middle East & Africa Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Type 10.2.1 Middle East & Africa Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Type (2017-2022) 10.2.2 Middle East & Africa Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Type (2023-2028) 10.2.3 Middle East & Africa Adult T-Cell Leukemia & Lymphoma Treatment Market Share by Type (2017-2028) 10.3 Middle East & Africa Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Application 10.3.1 Middle East & Africa Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Application (2017-2022) 10.3.2 Middle East & Africa Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Application (2023-2028) 10.3.3 Middle East & Africa Adult T-Cell Leukemia & Lymphoma Treatment Market Share by Application (2017-2028) 10.4 Middle East & Africa Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Country 10.4.1 Middle East & Africa Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Country (2017-2022) 10.4.2 Middle East & Africa Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Daiichi Sankyo Co. Ltd. 11.1.1 Daiichi Sankyo Co. Ltd. Company Details 11.1.2 Daiichi Sankyo Co. Ltd. Business Overview 11.1.3 Daiichi Sankyo Co. Ltd. Adult T-Cell Leukemia & Lymphoma Treatment Introduction 11.1.4 Daiichi Sankyo Co. Ltd. Revenue in Adult T-Cell Leukemia & Lymphoma Treatment Business (2017-2022) 11.1.5 Daiichi Sankyo Co. Ltd. Recent Developments 11.2 Seattle Genetics Inc. 11.2.1 Seattle Genetics Inc. Company Details 11.2.2 Seattle Genetics Inc. Business Overview 11.2.3 Seattle Genetics Inc. Adult T-Cell Leukemia & Lymphoma Treatment Introduction 11.2.4 Seattle Genetics Inc. Revenue in Adult T-Cell Leukemia & Lymphoma Treatment Business (2017-2022) 11.2.5 Seattle Genetics Inc. Recent Developments 11.3 miRagen Therapeutics Inc. 11.3.1 miRagen Therapeutics Inc. Company Details 11.3.2 miRagen Therapeutics Inc. Business Overview 11.3.3 miRagen Therapeutics Inc. Adult T-Cell Leukemia & Lymphoma Treatment Introduction 11.3.4 miRagen Therapeutics Inc. Revenue in Adult T-Cell Leukemia & Lymphoma Treatment Business (2017-2022) 11.3.5 miRagen Therapeutics Inc. Recent Developments 11.4 Celgene Corporation (Bristol-Myers Squibb) 11.4.1 Celgene Corporation (Bristol-Myers Squibb) Company Details 11.4.2 Celgene Corporation (Bristol-Myers Squibb) Business Overview 11.4.3 Celgene Corporation (Bristol-Myers Squibb) Adult T-Cell Leukemia & Lymphoma Treatment Introduction 11.4.4 Celgene Corporation (Bristol-Myers Squibb) Revenue in Adult T-Cell Leukemia & Lymphoma Treatment Business (2017-2022) 11.4.5 Celgene Corporation (Bristol-Myers Squibb) Recent Developments 11.5 HUYA Bioscience International 11.5.1 HUYA Bioscience International Company Details 11.5.2 HUYA Bioscience International Business Overview 11.5.3 HUYA Bioscience International Adult T-Cell Leukemia & Lymphoma Treatment Introduction 11.5.4 HUYA Bioscience International Revenue in Adult T-Cell Leukemia & Lymphoma Treatment Business (2017-2022) 11.5.5 HUYA Bioscience International Recent Developments 11.6 Novartis 11.6.1 Novartis Company Details 11.6.2 Novartis Business Overview 11.6.3 Novartis Adult T-Cell Leukemia & Lymphoma Treatment Introduction 11.6.4 Novartis Revenue in Adult T-Cell Leukemia & Lymphoma Treatment Business (2017-2022) 11.6.5 Novartis Recent Developments 11.7 BioCryst Pharmaceuticals 11.7.1 BioCryst Pharmaceuticals Company Details 11.7.2 BioCryst Pharmaceuticals Business Overview 11.7.3 BioCryst Pharmaceuticals Adult T-Cell Leukemia & Lymphoma Treatment Introduction 11.7.4 BioCryst Pharmaceuticals Revenue in Adult T-Cell Leukemia & Lymphoma Treatment Business (2017-2022) 11.7.5 BioCryst Pharmaceuticals Recent Developments 11.8 Kyowa Kirin 11.8.1 Kyowa Kirin Company Details 11.8.2 Kyowa Kirin Business Overview 11.8.3 Kyowa Kirin Adult T-Cell Leukemia & Lymphoma Treatment Introduction 11.8.4 Kyowa Kirin Revenue in Adult T-Cell Leukemia & Lymphoma Treatment Business (2017-2022) 11.8.5 Kyowa Kirin Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer

List of Tables Table 1. Global Adult T-Cell Leukemia & Lymphoma Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of Brentuximab Vedotin Table 3. Key Players of HBI-8000 Table 4. Key Players of Others Table 5. Global Adult T-Cell Leukemia & Lymphoma Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 6. Global Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 7. Global Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Region (2017-2022) & (US$ Million) Table 8. Global Adult T-Cell Leukemia & Lymphoma Treatment Market Share by Region (2017-2022) Table 9. Global Adult T-Cell Leukemia & Lymphoma Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 10. Global Adult T-Cell Leukemia & Lymphoma Treatment Market Share by Region (2023-2028) Table 11. Adult T-Cell Leukemia & Lymphoma Treatment Market Trends Table 12. Adult T-Cell Leukemia & Lymphoma Treatment Market Drivers Table 13. Adult T-Cell Leukemia & Lymphoma Treatment Market Challenges Table 14. Adult T-Cell Leukemia & Lymphoma Treatment Market Restraints Table 15. Global Adult T-Cell Leukemia & Lymphoma Treatment Revenue by Players (2017-2022) & (US$ Million) Table 16. Global Adult T-Cell Leukemia & Lymphoma Treatment Revenue Share by Players (2017-2022) Table 17. Global Top Adult T-Cell Leukemia & Lymphoma Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adult T-Cell Leukemia & Lymphoma Treatment as of 2021) Table 18. Ranking of Global Top Adult T-Cell Leukemia & Lymphoma Treatment Companies by Revenue (US$ Million) in 2021 Table 19. Global 5 Largest Players Market Share by Adult T-Cell Leukemia & Lymphoma Treatment Revenue (CR5 and HHI) & (2017-2022) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Adult T-Cell Leukemia & Lymphoma Treatment Product Solution and Service Table 22. Date of Enter into Adult T-Cell Leukemia & Lymphoma Treatment Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Type (2017-2022) & (US$ Million) Table 25. Global Adult T-Cell Leukemia & Lymphoma Treatment Revenue Market Share by Type (2017-2022) Table 26. Global Adult T-Cell Leukemia & Lymphoma Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 27. Global Adult T-Cell Leukemia & Lymphoma Treatment Revenue Market Share by Type (2023-2028) Table 28. Global Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Application (2017-2022) & (US$ Million) Table 29. Global Adult T-Cell Leukemia & Lymphoma Treatment Revenue Share by Application (2017-2022) Table 30. Global Adult T-Cell Leukemia & Lymphoma Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 31. Global Adult T-Cell Leukemia & Lymphoma Treatment Revenue Share by Application (2023-2028) Table 32. North America Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Type (2017-2022) & (US$ Million) Table 33. North America Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Type (2023-2028) & (US$ Million) Table 34. North America Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Application (2017-2022) & (US$ Million) Table 35. North America Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Application (2023-2028) & (US$ Million) Table 36. North America Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Country (2017-2022) & (US$ Million) Table 37. North America Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Country (2023-2028) & (US$ Million) Table 38. Europe Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Type (2017-2022) & (US$ Million) Table 39. Europe Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Type (2023-2028) & (US$ Million) Table 40. Europe Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Application (2017-2022) & (US$ Million) Table 41. Europe Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Application (2023-2028) & (US$ Million) Table 42. Europe Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Country (2017-2022) & (US$ Million) Table 43. Europe Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Country (2023-2028) & (US$ Million) Table 44. Asia Pacific Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Type (2017-2022) & (US$ Million) Table 45. Asia Pacific Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Type (2023-2028) & (US$ Million) Table 46. Asia Pacific Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Application (2017-2022) & (US$ Million) Table 47. Asia Pacific Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Application (2023-2028) & (US$ Million) Table 48. Asia Pacific Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Region (2017-2022) & (US$ Million) Table 49. Asia Pacific Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Region (2023-2028) & (US$ Million) Table 50. Latin America Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Type (2017-2022) & (US$ Million) Table 51. Latin America Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Type (2023-2028) & (US$ Million) Table 52. Latin America Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Application (2017-2022) & (US$ Million) Table 53. Latin America Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Application (2023-2028) & (US$ Million) Table 54. Latin America Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Country (2017-2022) & (US$ Million) Table 55. Latin America Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Country (2023-2028) & (US$ Million) Table 56. Middle East and Africa Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Type (2017-2022) & (US$ Million) Table 57. Middle East and Africa Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Type (2023-2028) & (US$ Million) Table 58. Middle East and Africa Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Application (2017-2022) & (US$ Million) Table 59. Middle East and Africa Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Application (2023-2028) & (US$ Million) Table 60. Middle East and Africa Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Country (2017-2022) & (US$ Million) Table 61. Middle East and Africa Adult T-Cell Leukemia & Lymphoma Treatment Market Size by Country (2023-2028) & (US$ Million) Table 62. Daiichi Sankyo Co. Ltd. Company Details Table 63. Daiichi Sankyo Co. Ltd. Business Overview Table 64. Daiichi Sankyo Co. Ltd. Adult T-Cell Leukemia & Lymphoma Treatment Product Table 65. Daiichi Sankyo Co. Ltd. Revenue in Adult T-Cell Leukemia & Lymphoma Treatment Business (2017-2022) & (US$ Million) Table 66. Daiichi Sankyo Co. Ltd. Recent Developments Table 67. Seattle Genetics Inc. Company Details Table 68. Seattle Genetics Inc. Business Overview Table 69. Seattle Genetics Inc. Adult T-Cell Leukemia & Lymphoma Treatment Product Table 70. Seattle Genetics Inc. Revenue in Adult T-Cell Leukemia & Lymphoma Treatment Business (2017-2022) & (US$ Million) Table 71. Seattle Genetics Inc. Recent Developments Table 72. miRagen Therapeutics Inc. Company Details Table 73. miRagen Therapeutics Inc. Business Overview Table 74. miRagen Therapeutics Inc. Adult T-Cell Leukemia & Lymphoma Treatment Product Table 75. miRagen Therapeutics Inc. Revenue in Adult T-Cell Leukemia & Lymphoma Treatment Business (2017-2022) & (US$ Million) Table 76. miRagen Therapeutics Inc. Recent Developments Table 77. Celgene Corporation (Bristol-Myers Squibb) Company Details Table 78. Celgene Corporation (Bristol-Myers Squibb) Business Overview Table 79. Celgene Corporation (Bristol-Myers Squibb) Adult T-Cell Leukemia & Lymphoma Treatment Product Table 80. Celgene Corporation (Bristol-Myers Squibb) Revenue in Adult T-Cell Leukemia & Lymphoma Treatment Business (2017-2022) & (US$ Million) Table 81. Celgene Corporation (Bristol-Myers Squibb) Recent Developments Table 82. HUYA Bioscience International Company Details Table 83. HUYA Bioscience International Business Overview Table 84. HUYA Bioscience International Adult T-Cell Leukemia & Lymphoma Treatment Product Table 85. HUYA Bioscience International Revenue in Adult T-Cell Leukemia & Lymphoma Treatment Business (2017-2022) & (US$ Million) Table 86. HUYA Bioscience International Recent Developments Table 87. Novartis Company Details Table 88. Novartis Business Overview Table 89. Novartis Adult T-Cell Leukemia & Lymphoma Treatment Product Table 90. Novartis Revenue in Adult T-Cell Leukemia & Lymphoma Treatment Business (2017-2022) & (US$ Million) Table 91. Novartis Recent Developments Table 92. BioCryst Pharmaceuticals Company Details Table 93. BioCryst Pharmaceuticals Business Overview Table 94. BioCryst Pharmaceuticals Adult T-Cell Leukemia & Lymphoma Treatment Product Table 95. BioCryst Pharmaceuticals Revenue in Adult T-Cell Leukemia & Lymphoma Treatment Business (2017-2022) & (US$ Million) Table 96. BioCryst Pharmaceuticals Recent Developments Table 97. Kyowa Kirin Company Details Table 98. Kyowa Kirin Business Overview Table 99. Kyowa Kirin Adult T-Cell Leukemia & Lymphoma Treatment Product Table 100. Kyowa Kirin Revenue in Adult T-Cell Leukemia & Lymphoma Treatment Business (2017-2022) & (US$ Million) Table 101. Kyowa Kirin Recent Developments Table 102. Research Programs/Design for This Report Table 103. Key Data Information from Secondary Sources Table 104. Key Data Information from Primary Sources List of Figures Figure 1. Global Adult T-Cell Leukemia & Lymphoma Treatment Market Share by Type: 2021 VS 2028 Figure 2. Brentuximab Vedotin Features Figure 3. HBI-8000 Features Figure 4. Others Features Figure 5. Global Adult T-Cell Leukemia & Lymphoma Treatment Market Share by Application: 2021 VS 2028 Figure 6. Hospitals Case Studies Figure 7. Clinics Case Studies Figure 8. Ambulatory Surgical Centers Case Studies Figure 9. Others Case Studies Figure 10. Adult T-Cell Leukemia & Lymphoma Treatment Report Years Considered Figure 11. Global Adult T-Cell Leukemia & Lymphoma Treatment Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 12. Global Adult T-Cell Leukemia & Lymphoma Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 13. Global Adult T-Cell Leukemia & Lymphoma Treatment Market Share by Region: 2021 VS 2028 Figure 14. Global Adult T-Cell Leukemia & Lymphoma Treatment Market Share by Players in 2021 Figure 15. Global Top Adult T-Cell Leukemia & Lymphoma Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adult T-Cell Leukemia & Lymphoma Treatment as of 2021) Figure 16. The Top 10 and 5 Players Market Share by Adult T-Cell Leukemia & Lymphoma Treatment Revenue in 2021 Figure 17. North America Adult T-Cell Leukemia & Lymphoma Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 18. North America Adult T-Cell Leukemia & Lymphoma Treatment Market Size Market Share by Type (2017-2028) Figure 19. North America Adult T-Cell Leukemia & Lymphoma Treatment Market Size Market Share by Application (2017-2028) Figure 20. North America Adult T-Cell Leukemia & Lymphoma Treatment Market Size Share by Country (2017-2028) Figure 21. United States Adult T-Cell Leukemia & Lymphoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. Canada Adult T-Cell Leukemia & Lymphoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. Europe Adult T-Cell Leukemia & Lymphoma Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 24. Europe Adult T-Cell Leukemia & Lymphoma Treatment Market Size Market Share by Type (2017-2028) Figure 25. Europe Adult T-Cell Leukemia & Lymphoma Treatment Market Size Market Share by Application (2017-2028) Figure 26. Europe Adult T-Cell Leukemia & Lymphoma Treatment Market Size Share by Country (2017-2028) Figure 27. Germany Adult T-Cell Leukemia & Lymphoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. France Adult T-Cell Leukemia & Lymphoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. U.K. Adult T-Cell Leukemia & Lymphoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Italy Adult T-Cell Leukemia & Lymphoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Russia Adult T-Cell Leukemia & Lymphoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Nordic Countries Adult T-Cell Leukemia & Lymphoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Asia-Pacific Adult T-Cell Leukemia & Lymphoma Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 34. Asia Pacific Adult T-Cell Leukemia & Lymphoma Treatment Market Size Market Share by Type (2017-2028) Figure 35. Asia Pacific Adult T-Cell Leukemia & Lymphoma Treatment Market Size Market Share by Application (2017-2028) Figure 36. Asia Pacific Adult T-Cell Leukemia & Lymphoma Treatment Market Size Share by Region (2017-2028) Figure 37. China Adult T-Cell Leukemia & Lymphoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Japan Adult T-Cell Leukemia & Lymphoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. South Korea Adult T-Cell Leukemia & Lymphoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Southeast Asia Adult T-Cell Leukemia & Lymphoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. India Adult T-Cell Leukemia & Lymphoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Australia Adult T-Cell Leukemia & Lymphoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million) List of Figures Figure 43. Latin America Adult T-Cell Leukemia & Lymphoma Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 44. Latin America Adult T-Cell Leukemia & Lymphoma Treatment Market Size Market Share by Type (2017-2028) Figure 45. Latin America Adult T-Cell Leukemia & Lymphoma Treatment Market Size Market Share by Application (2017-2028) Figure 46. Latin America Adult T-Cell Leukemia & Lymphoma Treatment Market Size Share by Country (2017-2028) Figure 47. Mexico Adult T-Cell Leukemia & Lymphoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 48. Brazil Adult T-Cell Leukemia & Lymphoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 49. Middle East & Africa Adult T-Cell Leukemia & Lymphoma Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 50. Middle East and Africa Adult T-Cell Leukemia & Lymphoma Treatment Market Size Market Share by Type (2017-2028) Figure 51. Middle East and Africa Adult T-Cell Leukemia & Lymphoma Treatment Market Size Market Share by Application (2017-2028) Figure 52. Middle East and Africa Adult T-Cell Leukemia & Lymphoma Treatment Market Size Share by Country (2017-2028) Figure 53. Turkey Adult T-Cell Leukemia & Lymphoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 54. Saudi Arabia Adult T-Cell Leukemia & Lymphoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 55. UAE Adult T-Cell Leukemia & Lymphoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 56. Daiichi Sankyo Co. Ltd. Revenue Growth Rate in Adult T-Cell Leukemia & Lymphoma Treatment Business (2017-2022) Figure 57. Seattle Genetics Inc. Revenue Growth Rate in Adult T-Cell Leukemia & Lymphoma Treatment Business (2017-2022) Figure 58. miRagen Therapeutics Inc. Revenue Growth Rate in Adult T-Cell Leukemia & Lymphoma Treatment Business (2017-2022) Figure 59. Celgene Corporation (Bristol-Myers Squibb) Revenue Growth Rate in Adult T-Cell Leukemia & Lymphoma Treatment Business (2017-2022) Figure 60. HUYA Bioscience International Revenue Growth Rate in Adult T-Cell Leukemia & Lymphoma Treatment Business (2017-2022) Figure 61. Novartis Revenue Growth Rate in Adult T-Cell Leukemia & Lymphoma Treatment Business (2017-2022) Figure 62. BioCryst Pharmaceuticals Revenue Growth Rate in Adult T-Cell Leukemia & Lymphoma Treatment Business (2017-2022) Figure 63. Kyowa Kirin Revenue Growth Rate in Adult T-Cell Leukemia & Lymphoma Treatment Business (2017-2022) Figure 64. Bottom-up and Top-down Approaches for This Report Figure 65. Data Triangulation Figure 66. Key Executives Interviewed

Daiichi Sankyo Co. Ltd. Seattle Genetics Inc. miRagen Therapeutics Inc. Celgene Corporation (Bristol-Myers Squibb) HUYA Bioscience International Novartis BioCryst Pharmaceuticals Kyowa Kirin